Page last updated: 2024-11-05

ticlopidine and Migraine with Aura

ticlopidine has been researched along with Migraine with Aura in 3 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt."7.73Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005)
"Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine."5.34Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007)
"The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt."3.73Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005)
"Transcatheter closure of an atrial septal defect using the Amplatzer septal occluder is a current treatment option in Japan, but is occasionally associated with transient exacerbation or new onset migraine."1.34Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report. ( Hatakeyama, K; Kobayashi, T; Soda, W; Tomita, H, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spencer, BT1
Qureshi, Y1
Sommer, RJ1
Wilmshurst, PT1
Nightingale, S1
Walsh, KP1
Morrison, WL1
Tomita, H1
Hatakeyama, K1
Soda, W1
Kobayashi, T1

Trials

1 trial available for ticlopidine and Migraine with Aura

ArticleYear
A retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions.
    Cephalalgia : an international journal of headache, 2014, Volume: 34, Issue:11

    Topics: Adolescent; Adult; Clopidogrel; Female; Foramen Ovale, Patent; Humans; Middle Aged; Migraine with Au

2014

Other Studies

2 other studies available for ticlopidine and Migraine with Aura

ArticleYear
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:9

    Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa

2005
Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
    Journal of cardiology, 2007, Volume: 49, Issue:6

    Topics: Adolescent; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Humans; Migraine with Aur

2007